Healthcare / Medical DistributionTokyo
$3040.00
+35.00 (+1.14%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $801.0M · quality 47.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.7B
P/E
18.3x
↓EV/EBITDA
1.5x
↓ROE
6.9%
↑Gross Margin
13.6%
↓Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+5.4%
FCF CAGR
-12.8%
FCF margin
0.5%
FCF / Net income
0.50x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $64.49B · net income $616.0M · FCF $307.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $64.49B | $64.49B | $61.55B | $58.20B | $55.15B |
| Net Income | $616.0M | $616.0M | $580.0M | $219.0M | $696.0M |
| EBITDA | $1.17B | $1.17B | $1.08B | $840.0M | $1.25B |
| EPS | 249.79 | 249.79 | 227.96 | 85.83 | 272.67 |
| Gross Margin | 13.6% | 13.6% | 13.8% | 13.8% | 14.0% |
| Operating Margin | 1.3% | 1.3% | 1.6% | 2.0% | 1.7% |
| Net Margin | 1.0% | 1.0% | 0.9% | 0.4% | 1.3% |
| Balance Sheet | |||||
| Current Ratio | 1.19 | 1.19 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $307.0M | $307.0M | $801.0M | $2.08B | $463.0M |
| Returns | |||||
| ROE | 6.9% | 6.9% | 6.8% | 2.8% | 8.7% |
| Valuation | |||||
| P/E | 18.30 | 18.30 | 11.56 | 23.90 | 6.95 |
| EV/EBITDA | 1.54 | 1.54 | 1.30 | -0.70 | 0.69 |
| P/B | 0.84 | 0.84 | 0.79 | 0.66 | 0.61 |
| Growth & Yield | |||||
| Revenue Growth | 4.8% | 4.8% | 5.8% | 5.5% | — |
| EPS Growth | 9.6% | 9.6% | 165.6% | -68.5% | — |
| Dividend Yield | 2.3% | 2.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
2.6%
EPS terminal req.
$269.75
Spread vs growth
7.0%
5Y implied EPS CAGR
5.5%
EPS terminal req.
$326.40
Spread vs growth
4.1%
10Y implied EPS CAGR
7.7%
EPS terminal req.
$525.67
Spread vs growth
1.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+17.3%
Start / end P/E
11.8x → 12.4x
EPS bridge
227.96 → 249.79
Residual
+0.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.